The global transplant diagnostics market is expected to reach USD 4.91 billion by 2023 from USD 3.25 billion in 2017, at a CAGR of 7.4%.
This report broadly segments the market into technology, product, transplant type, application, end user, and region. On the basis of technology, the market is segmented into molecular and non-molecular assay technologies. In 2018, the molecular assay technology segment is expected to account for the largest share of the market. This can be attributed to the expansion in the distribution network of key transplant diagnostic manufacturers across emerging countries (through strategic acquisitions, collaborations, and strengthening manufacturing capabilities) and increasing private funding to develop innovative transplant diagnostic products.
Key Market Drivers
1 Increasing Number of Transplant Procedures
2 Technological Advancements in the Field of Transplant Diagnostics
3 Increasing Public-Private Funding for Target Research Activities
4 Growing Burden of Infectious Diseases
Key Market Restraints
1 High Procedural Cost of NGS and PCR-Based Diagnostic Assays
2 Limited Reimbursements for Target Procedures
PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=2531061
Key Market Opportunities
1 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation
2 Increasing Public Awareness About Organ Donation and Transplantation Across Emerging Countries
Key Market Challenges
1 Significant Gap Between the Number of Organ Donors and Organs Required Annually
2 Procedural and Technical Limitations Associated With Donor-Recipient Screening
The major players in the market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and bioMerieux SA (France).
This report covers the market across four major regions, namely, North America, Europe, Asia Pacific, and the RoW. North America is expected to command the largest share of the market in 2018. The large share of North America in the global transplant diagnostics market is attributed to the high budgetary allocation for healthcare expenditure, large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics.
Know More: https://www.marketsandmarkets.com/Market-Reports/global-transplant-diagnostics-market-2531061.html
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com